Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
- PMID: 35314848
- DOI: 10.1038/s41590-022-01175-5
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination elicit CD4+ T cell responses to the spike protein, including circulating follicular helper T (cTFH) cells that correlate with neutralizing antibodies. Using a novel HLA-DRB1*15:01/S751 tetramer to track spike-specific CD4+ T cells, we show that primary infection or vaccination induces robust S751-specific CXCR5- and cTFH cell memory responses. Secondary exposure induced recall of CD4+ T cells with a transitory CXCR3+ phenotype, and drove expansion of cTFH cells transiently expressing ICOS, CD38 and PD-1. In both contexts, cells exhibited a restricted T cell antigen receptor repertoire, including a highly public clonotype and considerable clonotypic overlap between CXCR5- and cTFH populations. Following a third vaccine dose, the rapid re-expansion of spike-specific CD4+ T cells contrasted with the comparatively delayed increase in antibody titers. Overall, we demonstrate that stable pools of cTFH and memory CD4+ T cells established by infection and/or vaccination are efficiently recalled upon antigen reexposure and may contribute to long-term protection against SARS-CoV-2.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.
Similar articles
-
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.PLoS Pathog. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34270631 Free PMC article.
-
Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination.Front Immunol. 2022 Feb 14;13:827048. doi: 10.3389/fimmu.2022.827048. eCollection 2022. Front Immunol. 2022. PMID: 35237272 Free PMC article.
-
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.J Exp Med. 2021 Dec 6;218(12):e20211327. doi: 10.1084/jem.20211327. Epub 2021 Oct 14. J Exp Med. 2021. PMID: 34647971 Free PMC article.
-
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3. J Leukoc Biol. 2022. PMID: 34730247 Free PMC article. Review.
-
T follicular helper cell responses to SARS-CoV-2 vaccination among healthy and immunocompromised adults.Immunol Cell Biol. 2023 Jul;101(6):504-513. doi: 10.1111/imcb.12635. Epub 2023 Mar 23. Immunol Cell Biol. 2023. PMID: 36825370 Free PMC article. Review.
Cited by
-
New tool to investigate spike-specific CD4+ T cells.Nat Rev Immunol. 2022 May;22(5):275. doi: 10.1038/s41577-022-00723-2. Nat Rev Immunol. 2022. PMID: 35396463 Free PMC article. No abstract available.
-
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals.Signal Transduct Target Ther. 2023 Oct 6;8(1):393. doi: 10.1038/s41392-023-01650-x. Signal Transduct Target Ther. 2023. PMID: 37802996 Free PMC article.
-
Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments.Front Immunol. 2023 Apr 28;14:1087996. doi: 10.3389/fimmu.2023.1087996. eCollection 2023. Front Immunol. 2023. PMID: 37187728 Free PMC article.
-
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature.Vaccines (Basel). 2024 Sep 14;12(9):1051. doi: 10.3390/vaccines12091051. Vaccines (Basel). 2024. PMID: 39340081 Free PMC article. Review.
-
Clonal composition and persistence of antigen-specific circulating T follicular helper cells.Eur J Immunol. 2023 Feb;53(2):e2250190. doi: 10.1002/eji.202250190. Epub 2022 Dec 25. Eur J Immunol. 2023. PMID: 36480793 Free PMC article.
References
-
- Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205–1211 (2021). - DOI
-
- Gilbert, P. B. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy trial. Science 375, 43–50 (2022). - DOI
-
- Juno, J. A. et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat. Med. 26, 1428–1434 (2020). - DOI
-
- Koutsakos, M. et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep. Med. 2, 100208 (2021). - DOI
-
- Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell https://doi.org/10.1016/j.cell.2020.09.038 (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous